James J. Maciejko

1.3k total citations · 1 hit paper
30 papers, 879 citations indexed

About

James J. Maciejko is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, James J. Maciejko has authored 30 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in James J. Maciejko's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Mast cells and histamine (3 papers). James J. Maciejko is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Mast cells and histamine (3 papers). James J. Maciejko collaborates with scholars based in United States. James J. Maciejko's co-authors include David R. Holmes, Bruce A. Kottke, Simon J.T. Mao, Dac M. Dinh, Alan R. Zinsmeister, Shuqi Mao, Roger D. Blevins, Michael P. Smith, S S Levinson and George J. Grega and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Circulation Research.

In The Last Decade

James J. Maciejko

30 papers receiving 792 citations

Hit Papers

Apolipoprotein A-I as a Marker of Angiographically Assess... 1983 2026 1997 2011 1983 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James J. Maciejko United States 12 419 409 189 155 130 30 879
J D Morrisett United States 13 316 0.8× 440 1.1× 279 1.5× 154 1.0× 142 1.1× 18 928
J. Frohlich Canada 16 388 0.9× 538 1.3× 177 0.9× 185 1.2× 159 1.2× 33 887
Masaharu Kubo Japan 18 306 0.7× 346 0.8× 126 0.7× 212 1.4× 83 0.6× 46 803
James P. Corsetti United States 20 373 0.9× 460 1.1× 186 1.0× 234 1.5× 144 1.1× 49 1.1k
P Segal Israel 17 351 0.8× 245 0.6× 239 1.3× 211 1.4× 70 0.5× 33 908
P Douste‐Blazy France 11 259 0.6× 302 0.7× 147 0.8× 140 0.9× 110 0.8× 27 625
G. Bittolo‐Bon Italy 13 476 1.1× 786 1.9× 225 1.2× 291 1.9× 220 1.7× 20 1.5k
A. Gustafson Sweden 18 399 1.0× 312 0.8× 120 0.6× 177 1.1× 162 1.2× 63 881
Ryoyu Takeda Japan 19 481 1.1× 414 1.0× 209 1.1× 186 1.2× 62 0.5× 57 973
Robert S. Rosenson United States 13 368 0.9× 525 1.3× 359 1.9× 129 0.8× 142 1.1× 26 961

Countries citing papers authored by James J. Maciejko

Since Specialization
Citations

This map shows the geographic impact of James J. Maciejko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Maciejko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Maciejko more than expected).

Fields of papers citing papers by James J. Maciejko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Maciejko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Maciejko. The network helps show where James J. Maciejko may publish in the future.

Co-authorship network of co-authors of James J. Maciejko

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Maciejko. A scholar is included among the top collaborators of James J. Maciejko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Maciejko. James J. Maciejko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solomon, Robert, et al.. (2022). Evaluating Statin Tolerability in Historically Intolerant Patients After Correcting for Subclinical Hypothyroidism and Vitamin D Insufficiency. High Blood Pressure & Cardiovascular Prevention. 29(5). 409–415. 1 indexed citations
2.
Maciejko, James J., et al.. (2019). Assessment and Management of Patients with Hyperlipidemia Referred for Initiation of PCSK9 Inhibitor Therapy: A Lipid Clinic Experience. American Journal of Cardiovascular Drugs. 19(6). 553–559. 3 indexed citations
3.
Maciejko, James J., et al.. (2017). Lysosomal acid lipase deficiency in all siblings of the same parents. Journal of clinical lipidology. 11(2). 567–574. 4 indexed citations
4.
Maciejko, James J.. (2017). Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency. American Journal of Cardiovascular Drugs. 17(3). 217–231. 19 indexed citations
6.
Bakshi, Nasir, et al.. (2007). The Effect of Freezing and Long-Term Storage on the Stability of Cardiac Troponin T. American Journal of Clinical Pathology. 128(1). 164–167. 39 indexed citations
7.
Hashem, Mustafa, Howard Rosman, Aamir Cheema, et al.. (2006). Usefulness of Clinical Evaluation, Troponins, and C-Reactive Protein in Predicting Mortality Among Stable Hemodialysis Patients. The American Journal of Cardiology. 98(9). 1283–1287. 20 indexed citations
8.
Nordstrom, Cheryl K., Thomas LaLonde, Arshad Ali, et al.. (2006). The Impact of Coronary Artery Disease Risk Factors on Intravascular Ultrasound‐Derived Morphologic Indices of Human Coronaries. Echocardiography. 23(4). 308–311. 9 indexed citations
9.
Maciejko, James J.. (2004). Atherosclerosis Risk Factors. 4 indexed citations
10.
Santinga, John T., et al.. (1994). Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. The American Journal of Medicine. 96(6). 509–515. 26 indexed citations
11.
Maciejko, James J.. (1994). Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia. Archives of Family Medicine. 3(11). 955–960. 18 indexed citations
12.
Holt, William F., et al.. (1991). CP-66,948: An antisecretory histamine H2-receptor antagonist with mucosal protective properties. Digestive Diseases and Sciences. 36(12). 1721–1728. 8 indexed citations
13.
Maciejko, James J., et al.. (1987). New assay of apolipoproteins A-I and B by rate nephelometry evaluated.. Clinical Chemistry. 33(11). 2065–2069. 80 indexed citations
15.
Maciejko, James J., David R. Holmes, Bruce A. Kottke, et al.. (1983). Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease. New England Journal of Medicine. 309(7). 385–389. 451 indexed citations breakdown →
16.
Bell, Thomas G., William L. Smith, W. D. Oxender, & James J. Maciejko. (1980). Biologic Interaction of Prostaglandins, Thromboxane, and Prostacyclin: Potential Nonreproductive Veterinary Clinical Applications. Journal of the American Veterinary Medical Association. 176(10). 1195–1200. 3 indexed citations
17.
Maciejko, James J., et al.. (1978). Effects of locally and systemically infused bradykinin on transvascular fluid and protein transfer in the canine forelimb.. Journal of Pharmacology and Experimental Therapeutics. 205(1). 221–235. 11 indexed citations
18.
Maciejko, James J., et al.. (1978). Antagonism of histamine edema formation by catecholamines. American Journal of Physiology-Heart and Circulatory Physiology. 234(2). H180–H185. 20 indexed citations
19.
Maciejko, James J., et al.. (1977). Effects of systemically infused histamine on transvascular fluid and protein transfer. American Journal of Physiology-Heart and Circulatory Physiology. 233(1). H148–H153. 9 indexed citations
20.
Doyle, Michael P., et al.. (1973). Reaction between azide and nitronium ions. Formation and decomposition of nitryl azide. Journal of the American Chemical Society. 95(3). 952–953. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026